-PDF Download- Fast Facts Egfr Exon 20 Insertion Mutations In Nsclc EBOOK

Fast Facts: EGFR Exon 20 Insertion Mutations in NSCLC

Author: Julia Rotow

Publisher: Karger Medical and Scientific Publishers

Published: 2022-06-30

Total Pages: 62

ISBN-13: 3318070203

Lung cancer is still a major cause of death globally, but the development of personalized, precision medicine has had a marked effect on treatment management and improved clinical outcomes, particularly for those with advanced stage non-small-cell lung cancer (NSCLC). EGFR mutations are the third most common mutation found in patients with advanced stage NSCLC. First-line treatment with a traditional epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) is indicated for most patients, but not for patients with EGFR exon 20 insertion mutations (ex20ins). Instead, recent approvals of an EGFR ex20ins-specific TKI (mobocertinib) and a bispecific antibody (amivantamab) targeting both EGFR and mesenchymalepithelial transition factor (MET) offer the potential for improved outcomes in this patient population. Furthermore, new approaches to treatment continue to be developed and trials for new agents with greater activity against ex20ins mutations are ongoing. Table of Contents: • EGFR and mutations • EGFR mutation testing • Treatment decisions • Therapies in development

Fast Facts: EGFR Exon 20 Insertion Mutations in NSCLC

Author: J. Rotow

Publisher: Karger Medical and Scientific Publishers

Published: 2022-06-13

Total Pages: 62

ISBN-13: 3318071366

DOWNLOAD EBOOK →

Molecular Pathology of Lung Cancer

Author: Philip T. Cagle

Publisher: Springer Science & Business Media

Published: 2012-06-14

Total Pages: 217

ISBN-13: 1461431972

DOWNLOAD EBOOK →

As with other books in the Molecular Pathology Library Series, Molecular Pathology of Lung Cancer bridges the gap between the molecular specialist and the clinical practitioner, including the surgical pathologist who now has a key role in decisions regarding molecular targeted therapy for lung cancer. Molecular Pathology of Lung Cancer provides the latest information and current insights into the molecular basis for lung cancer, including precursor and preinvasive lesions, molecular diagnosis, molecular targeted therapy, molecular prognosis, molecular radiology and related fields for lung cancer generally and for the specific cell types. As many fundamental concepts about lung cancer have undergone revision in only the past few years, this book will likely be the first to comprehensively cover the new molecular pathology of lung cancer. It provides a foundation in this field for pathologists, medical oncologists, radiation oncologists, thoracic surgeons, thoracic radiologists and their trainees, physician assistants, and nursing staff.

Fast Facts: Non-Small-Cell Lung Cancer

Author: Mary O'Brien

Publisher: Karger Medical and Scientific Publishers

Published: 2022-02-28

Total Pages: 148

ISBN-13: 3318070106

DOWNLOAD EBOOK →

Despite an overall decrease in tobacco use, lung cancer (80–85% of which is non-small-cell lung cancer [NSCLC]) is still the leading cause of cancer death in both men and women worldwide. Annual low-dose CT screening of high-risk individuals has the potential to detect early-stage tumors, which can usually be successfully treated with a combination of surgery, radiotherapy and chemotherapy and, in some cases, targeted therapy. However, most patients with NSCLC still present with advanced or metastatic disease. For these patients, initial therapy is guided by the tumor’s molecular characteristics and patient’s performance status. Targeted therapies have significantly improved clinical outcomes and, for some patients with no targetable genetic alterations, immunotherapy has demonstrated significant overall survival benefit. This insightful guide is designed to bring you up to speed with the latest developments and is important reading for all health professionals and medical trainees working in this fast-moving field. Table of Contents: • Prevention and screening • Diagnosis and staging • Surgery • Radiotherapy • Systemic therapy in non-metastatic NSCLC • Systemic therapy in advanced-stage/metastatic disease without a molecular driver • Personalized treatment in advanced NSCLC • Oligometastatic disease and brain metastases

Pathology of Sinonasal Tumors and Tumor-Like Lesions

Author: Alessandro Franchi

Publisher: Springer Nature

Published: 2019-11-11

Total Pages: 241

ISBN-13: 3030298485

DOWNLOAD EBOOK →

This book provides a comprehensive, up-to-date review of the field of diagnostic histopathology of sinonasal tumors and tumor-like lesions. It includes well-known and recently described structures, focusing on their epidemiological, clinical, radiological, and molecular features. It also discusses the latest surgical and medical treatment of these tumors. Primarily written for pathologists and pathology residents, the topics discussed make it a valuable resource for head and neck surgeons, radiologists, oncologists, and other clinical physicians. Written by experts in the field, this book further our understanding of the pathology of sinonasal tumors.

Targeted Therapies for Lung Cancer

Author: Ravi Salgia

Publisher: Springer

Published: 2019-06-26

Total Pages: 238

ISBN-13: 3030178323

DOWNLOAD EBOOK →

This book contextualizes translational research and provides an up to date progress report on therapies that are currently being targeted in lung cancer. It is now well established that there is tremendous heterogeneity among cancer cells both at the inter- and intra-tumoral level. Further, a growing body of work highlights the importance of targeted therapies and personalized medicine in treating cancer patients. In contrast to conventional therapies that are typically administered to the average patient regardless of the patient’s genotype, targeted therapies are tailored to patients with specific traits. Nonetheless, such genetic changes can be disease-specific and/or target specific; thus, the book addresses these issues manifested in the somatically acquired genetic changes of the targeted gene. Each chapter is written by a leading medical oncologist who specializes in thoracic oncology and is devoted to a particular target in a specific indication. Contributors provide an in-depth review of the literature covering the mechanisms underlying signaling, potential cross talk between the target and downstream signaling, and potential emergence of drug resistance.

Classification and Regression Trees

Author: Leo Breiman

Publisher: Routledge

Published: 2017-10-19

Total Pages: 253

ISBN-13: 135146048X

DOWNLOAD EBOOK →

The methodology used to construct tree structured rules is the focus of this monograph. Unlike many other statistical procedures, which moved from pencil and paper to calculators, this text's use of trees was unthinkable before computers. Both the practical and theoretical sides have been developed in the authors' study of tree methods. Classification and Regression Trees reflects these two sides, covering the use of trees as a data analysis method, and in a more mathematical framework, proving some of their fundamental properties.

Fast Facts: Comprehensive Genomic Profiling

Author: Bernardo L. Rapoport

Publisher: Karger Medical and Scientific Publishers

Published: 2020-10-20

Total Pages: 109

ISBN-13: 3318068187

DOWNLOAD EBOOK →

Cancer is a multifaceted disease in which genetic changes induce uncontrolled tumor growth. Genomic characterization of cancer is now leading to better diagnostic, prognostic and predictive biomarkers, and effective individualized management. 'Fast Facts: Comprehensive Genomic Profiling' provides a crash course in the science, methods and application of genomic profiling. Assuming only the most basic knowledge – or memory – of cell biology, the authors provide an overview of DNA and RNA biology and next-generation sequencing. This sets in context the descriptions of prognostic and predictive biomarkers for different cancer types and genomic-based treatments. Finally, but importantly, some of the practicalities of gaining and interpreting genomic information are described. Whether you need a primer or a refresher, this short colorful book demystifies this complex subject. Contents: • Genetic mutations and biomarkers • Understanding next-generation sequencing • Elements of comprehensive genomic profiles • Role in precision oncology • Predictive and prognostic biomarkers • Overcoming barriers to genotype-directed therapy

Small Molecules in Oncology

Author: Uwe M. Martens

Publisher: Springer Science & Business Media

Published: 2010-01-14

Total Pages: 242

ISBN-13: 3642012221

DOWNLOAD EBOOK →

Extensive research into the molecular mechanisms of cancer disease has heralded a new age of targeted therapy. In malignant cells, key proteins that are crucial to tumor growth and survival are now being targeted directly with rationally designed inhibitors. Apart from monoclonal antibodies, small molecule therapeutics such as oncogenic protein kinase inhibitors are attracting a vast amount of investigational attention. This textbook, written by acknowledged experts, provides a broad overview of the small molecules currently used for the treatment of malignant diseases and discusses interesting novel compounds that are in the process of clinical development to combat cancer.

Molecular Diagnosis and Targeting for Thoracic and Gastrointestinal Malignancy

Author: Yutaka Shimada

Publisher: Springer

Published: 2017-11-29

Total Pages: 156

ISBN-13: 9811064695

DOWNLOAD EBOOK →

This volume focuses on the clinical applications of molecular diagnosis and targeted therapy from the viewpoint of oncologists specializing in specific organs. In addition, it discusses the role of molecular diagnosis and targeted therapy in the course of surgical treatment. Recent, rapid advances in molecular biology have shed new light on the mechanisms of cancer progression, and molecularly targeted drugs have been used to treat a variety of malignant diseases. For the diagnosis and precise treatment of cancer, analysis of the molecular background of the tumor is indispensable. However, there are both tumor-specific and comprehensive mechanisms involved in these processes. Accordingly, a firm grasp of molecular diagnosis and targeted therapies for different tumors is vital for clinicians and basic researchers alike. This book provides essential information and the latest findings on molecular diagnosis and targeted therapy for thoracic and gastrointestinal malignancies. Though primarily intended for clinical and basic oncologists, it also offers a useful guide for clinicians who are interested in this field and are considering getting started in molecular diagnosis and targeted therapy.